Clinical Trials · NCT01403038
An Open-label Study of the Effects of Elagolix in Adult Premenopausal Females
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Enrollment
- 216
- Start date
- Jun 2011
- Locations
- 22 sites, United States, Puerto Rico
- Primary endpoint
- Ovulation Classification